Deliverable D7.1 Guidance for the interaction between HTD and HTA is now published. 

EUnetHTA 21 is pleased to announce the publication of the deliverable D7.1. This EUnetHTA 21 deliverable focusses on the guidance for the interaction between HTA bodies and Health Technology Developers (HTD) during Joint Clinical Assessments (JCA) Joint Scientific Consultations (JSC), the process for a factual accuracy check and the process for handling confidential information. More information […]

Deliverable D4.4 on Endpoints is now published. 

EUnetHTA 21 is pleased to announce the publication of the deliverable  D4.4 on Endpoints.  The objective of this deliverable was to develop a practical guideline on how to deal with the several issues encountered around the assessment of endpoints in JCAs. More information can be found here: https://www.eunethta.eu/jointhtawork/ Many thanks to all involved in the development of the deliverables!

EUnetHTA 21 announces publication of five deliverables

EUnetHTA 21 is pleased to announce the publication of five deliverables:  D4.3.1 Practical guideline for direct and indirect comparisons, D4.5 Practical guideline on applicability of evidence, D4.6 Practical guideline on validity of clinical studies, D5.1 Guidance for submission dossier and D5.2 Guidance for JCA Report Template. More information can be found here: https://www.eunethta.eu/jointhtawork/ Many thanks to […]

EUnetHTA 21-EMA Bilateral Meeting Minutes available now.

We are pleased to announce the publication of the EUnetHTA 21 – EMA bilateral meeting minutes. The joint meeting was held in June 2022. It was the 22nd meeting EUnetHTA and EMA have had during the long-standing collaboration, discussing the Joint Workplan, Cooperation on “Horizon Scanning” of pharmaceuticals coming into healthcare system and the future format […]

The 2nd Open Call for Joint Scientific Consultations (JSCs) closed and new products for the 2nd batch of parallel EMA/EUnetHTA 21 JSC have been selected

The EUnetHTA 21 2nd Open Call for applications from the pharmaceutical industry for Joint Scientific Consultations (JSCs) closed on 31 August, 2022. The EUnetHTA 21 Committee for Scientific Consistency and Quality (CSCQ) JSC reviewed the applications received and selected five additional JSCs to be conducted within the framework of EUnetHTA 21. These five JSCs will […]

This website uses cookies to ensure you get the best experience on our website. By using the website you agree to our Privacy Policy and our Terms of Use.